A simple blood test for food intolerances could go a long way in relieving patients of uncomfortable and potentially dangerous gastro-esophageal reflux disease (GERD)symptoms. This study presents a unique and non-invasive testing method to identify food intolerances, which could reduce symptoms by as much as 50%, without the use of proton pump inhibitors. Research By Michele Caselli, Giovanni Zuliani, Francesca Cassol, Nadia Fusetti, Elena Zeni, Natalina Lo Cascio, Cecilia Soavi and Sergio Gullini, Published in World Journal of Gastroenterology, Dec.2014. Edited excerpts by Kimberly Lord Stewart.
The extremely common condition of GERD is characterized by symptoms of heartburn and acid regurgitation and frequently presents itself as a chronic relapsing disease course. The etiopathogenesis of GERD remains largely unknown even though up to 20% of the adult population in Western Countries is affected by reflux symptoms on a weekly basis. Notably, at least 50% of GERD patients remain on continuous medical therapy, which may predispose individuals to an increased risk of cancer.
Diagnostic examinations – endoscopy, 24-h pH monitoring, barium esophageal radiography, proton pump inhibitor (PPI) test, gastro-esophageal scintigraphy – can help diagnose but they are not diagnostic in nature. This double blind, randomized, controlled pilot trial was performed to investigate the clinical response of GERD symptoms to exclusion diets based on food intolerance tests. The pilot study tested 38 GERD patients who were partially or completely non-responders to proton pump inhibitors (PPI) treatment.
This study suggests a simple leukocytotoxic test, based on the optical evaluation of leukocytes in a blood sample that has come into direct contact with specific food substances, may provide a diagnostic tool for treatment. This pilot study reveals that undiagnosed food intolerances, identified by this test, may help significantly reduce the incidence of GERD.
The patients in this study included only non-responders to PPI therapy or partially responders (i.e., patients experiencing only slight reduction of symptoms after 4 wk of treatment or having an initial response to PPI treatment but with relapses of symptoms during the 4 wk of PPI treatment) were recruited.
1. Fasting blood samples were taken from each of the 38 patients.
2. Leukocytotoxic test was performed by incubating the blood with a panel of 60 food items to be tested.
3. A “true” diet excluding food items inducing moderate-severe reactions, and a “control” diet including them was developed for each patient.
4. Then, twenty patients received the “true” diet and 18 the “control” diet; after one month (T1) symptoms severity was scored by the GERD impact scale (GIS).
5. Hence, patients in the “control” group were switched to the “true” diet, and symptom severity was re-assessed after three months (T2).
All patients reacted moderately/severely to at least 1 food (range: 5-19), with a significantly greater number of food substances inducing reaction in controls compared with the “true” diet group (11.6 vs 7.0, P < 0.001). Food items more frequently involved were milk, lettuce, brewer’s yeast, pork, coffee, rice, sole, asparagus, and tuna, followed by eggs, tomato, grain, shrimps, and chemical yeast.
FOOD INTOLERANCE & LEUKOCYTOTOXIC TESTS
The leukocytotoxic test is based on the optical evaluation of leukocytes in a blood sample that has come into direct contact with specific food substances. On the basis of leukocytes observation, degrees of reaction to the food extracts are rated according to the following scale: level 0 = negative, level 1 = slightly positive, level 2 = moderately positive, and level 3 = highly positive. These levels correspond to (1) the state of the leukocytes, which react by swelling, then developing vacuoles, and finally deteriorate; and (2) the total number of leukocytes that react.
Currently, the dedicated task forces consider these tests to have a poor clinical specificity and sensitivity. The researchers hypothesized that the most important reason might be the very high frequency of mild positive results. Therefore, the researchers decided to exclude level 1 of the scale, directly starting from level 2. In this way, they could demonstrate a strong difference between GERD patients and controls, and the test-based exclusion diet resulted effective in all patients.
One month after the beginning of the elimination diet (T1), the “true” test-based diet group experienced an important reduction (-50%) in GIS global score (from 6.6 ±1.9 to 3.3 ± 1.7, P = 0.001). Patients in the “control” diet group also experienced a significant reduction in GIS global score (-26.9%, from 6.7 ± 1.7 to 4.9 ± 2.8, P = 0.02), although it was much smaller compared to “true” diet group (see the entire study for more on the study results).
KEY TAKE AWAYS
1. This preliminary data seem to suggest that pathogenetic mechanisms related to food intolerance may play a role in the etiopathogenesis of GERD. The modifications of the GIS score from T0 to T2 in the two groups of patients clearly shows that the entity of reduction in the “true” diet group at T1 is equal to the reduction observed for the “control” group at T2. This observation seems to confirm the effectiveness of “true” test-based diet in reducing the impact of GERD symptoms of about 4%-50%.
2. The researchers previously suggested that a rationale for the use of a leukocytotoxic test might be related to the role of T regulatory cells and food intolerances. Unlike allergic reactions, which involve the down regulation of T-regulatory cells, this study supports the idea that food intolerance reactions may result from the up regulation of T-regulatory cells. The pathogenic basis for food intolerance may be caused by an up-regulation of T-regulatory cells that induces an increase in both IgG4 and toxic reactions in blood leukocytes.
The results suggest that, although not all GERD symptoms might be attributed to food intolerance, this pathogenetic condition may play a role in GERD symptoms development. Thus, test-based exclusion diets may be considered an effective and cost-effective therapeutic tool, poor of adverse events, and particularly indicated when PPI treatment is not effective or not indicated. When considering only the moderate-severe reactions, the leukocytotoxic test appears to be effective in identifying the food substances whose exclusion is associated with clinical improvement of GERD symptoms.LINK HERE TO FULL TEXT STUDY